Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Headache and IL28B[original query] |
---|
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet (London, England) 2014 Aug 384 (9941): 403-13. Jacobson Ira M, Dore Gregory J, Foster Graham R, Fried Michael W, Radu Monica, Rafalsky Vladimir V, Moroz Larysa, Craxi Antonio, Peeters Monika, Lenz Oliver, Ouwerkerk-Mahadevan Sivi, De La Rosa Guy, Kalmeijer Ronald, Scott Jane, Sinha Rekha, Beumont-Mauviel Mar |
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet (London, England) 2014 Aug 384 (9941): 414-26. Manns Michael, Marcellin Patrick, Poordad Fred, de Araujo Evaldo Stanislau Affonso, Buti Maria, Horsmans Yves, Janczewska Ewa, Villamil Federico, Scott Jane, Peeters Monika, Lenz Oliver, Ouwerkerk-Mahadevan Sivi, De La Rosa Guy, Kalmeijer Ronald, Sinha Rekha, Beumont-Mauviel Mar |
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection. Hepatology (Baltimore, Md.) 2014 Jun 59 (6): 2083-91. Kumada Hiromitsu, Suzuki Yoshiyuki, Ikeda Kenji, Toyota Joji, Karino Yoshiyasu, Chayama Kazuaki, Kawakami Yoshiiku, Ido Akio, Yamamoto Kazuhide, Takaguchi Koichi, Izumi Namiki, Koike Kazuhiko, Takehara Tetsuo, Kawada Norifumi, Sata Michio, Miyagoshi Hidetaka, Eley Timothy, McPhee Fiona, Damokosh Andrew, Ishikawa Hiroki, Hughes Er |
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. The New England journal of medicine 2014 Jan 370 (3): 211-21. Sulkowski Mark S, Gardiner David F, Rodriguez-Torres Maribel, Reddy K Rajender, Hassanein Tarek, Jacobson Ira, Lawitz Eric, Lok Anna S, Hinestrosa Federico, Thuluvath Paul J, Schwartz Howard, Nelson David R, Everson Gregory T, Eley Timothy, Wind-Rotolo Megan, Huang Shu-Pang, Gao Min, Hernandez Dennis, McPhee Fiona, Sherman Diane, Hindes Robert, Symonds William, Pasquinelli Claudio, Grasela Dennis M, |
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study. Hepatology (Baltimore, Md.) 2016 Jan . Kwo Paul, Gitlin Norman, Nahass Ronald, Bernstein David, Etzkorn Kyle, Rojter Sergio, Schiff Eugene, Davis Mitchell, Ruane Peter, Younes Ziad, Kalmeijer Ronald, Sinha Rekha, Peeters Monika, Lenz Oliver, Fevery Bart, De La Rosa Guy, Scott Jane, Witek Jam |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: